What is Calidi Biotherapeutics Inc.?
, a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 1.65M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.